Human epidermal growth factor receptor 2 (HER2) belongs to the epidermal growth factor receptor (EGFR) family, and its overexpression/amplification has been confirmed in various malignant neoplasms, such as breast cancer (BC), prostate cancer, and lung cancer. This evidence concerns the gene EGFR and prostate cancer.